| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 288,291 | 294,944 | 267,960 | 282,132 |
| Marketable securities | 923,361 | 950,266 | 807,010 | 868,205 |
| Prepaid expenses and other current assets | 55,301 | 23,478 | 23,577 | 25,127 |
| Total current assets | 1,266,953 | 1,268,688 | 1,098,547 | 1,175,464 |
| Total property and equipment | 200,979 | 198,627 | 196,891 | NaN |
| Less accumulated depreciation | 99,732 | 94,127 | 88,601 | NaN |
| Property and equipment, net | 101,247 | 104,500 | 108,290 | 108,824 |
| Restricted cash | 6,693 | 6,676 | 6,656 | 6,633 |
| Operating lease right-of-use assets | 98,148 | 100,679 | 96,995 | 99,568 |
| Other assets | 7,757 | 634 | 593 | 668 |
| Total assets | 1,480,798 | 1,481,177 | 1,311,081 | 1,391,157 |
| Accounts payable | 12,286 | 10,231 | 9,545 | 10,556 |
| Accrued expenses and other current liabilities | 39,291 | 55,267 | 42,314 | 40,904 |
| Current portion of derivative liabilities | 5,200 | 7,700 | 6,500 | 3,900 |
| Current portion of deferred revenue | 304 | 6,659 | 110,320 | 105,822 |
| Current portion of lease liability | 14,781 | 14,364 | 12,688 | 12,949 |
| Current portion of contingent consideration liabilities | 2,703 | 2,714 | 1,192 | NaN |
| Total current liabilities | 74,565 | 96,935 | 182,559 | 174,131 |
| Long-term lease liability | 135,848 | 139,759 | 138,732 | 141,854 |
| Long-term portion of derivative liabilities | NaN | 0 | 6,654 | 6,497 |
| Long-term portion of deferred revenue | NaN | 0 | 10,160 | 20,319 |
| Long-term portion of contingent consideration liabilities | 5,449 | 5,952 | 6,708 | 1,186 |
| Long-term portion of debt | 100,193 | NaN | NaN | NaN |
| Other liabilities | 305 | 173 | 266 | 357 |
| Total liabilities | 316,360 | 242,819 | 345,079 | 344,344 |
| Common stock, 0.01 par value 250,000,000 shares authorized, 102,741,848 and 101,748,962 issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1,027 | 1,017 | 1,014 | 1,008 |
| Additional paid-in capital | 2,900,018 | 2,877,449 | 2,855,118 | 2,823,987 |
| Accumulated other comprehensive (loss) income | -1,070 | 1,111 | 790 | 10 |
| Accumulated deficit | -1,735,537 | -1,641,219 | -1,890,920 | -1,778,192 |
| Total stockholders' equity | 1,164,438 | 1,238,358 | 966,002 | 1,046,813 |
| Total liabilities and stockholders' equity | 1,480,798 | 1,481,177 | 1,311,081 | 1,391,157 |
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)